More proof that the Coriolus Versicolor and its main therapeutic component are worth considering when battling cancer and the side effects of the common treatments.
Led by, Dorothy Cimino Brown from the University of Pennsylvania School of Veterinary Medicine, the researchers said the ‘promising findings’ offer hope that the compound may one day offer cancer patients — human and canine alike — a viable new ally in the battle against cancer.
“There have been a series of studies looking at groups of people with cancer,” Cimino Brown said. “The issue with those studies is that they weren’t necessarily measuring what most people would think is the most clinically important result, which is, do people taking PSP live longer?”
Based on the ultimate endpoints of how quickly the tumors progressed and how long dogs suffering from a natural form of cancer survived when given the supplement, the research team suggests that PSP supplementation may be effective in fighting the tumors.
“We were shocked,” Cimino Brown said. “Prior to this, the longest reported median survival time of dogs with hemangiosarcoma of the spleen that underwent no further treatment was 86 days. We had dogs that lived beyond a year with nothing other than this mushroom as treatment.”
To address this critical question, Cimino Brown and her team began research in dogs suffering from naturally occurring hemangiosarcoma (an aggressive, invasive cancer that arises from the blood cells and typically affects the spleen.)
The results of the researchers’ trial suggest that the PSP supplement was effectively fighting the tumors.
The full article can be found here:
Extensive background on PSP and the Coriolus versicolor medicinal mushroom can be found here.